Opportunity Analysis of H1N1 (swine flu) Vaccination Market

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918). ( http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html )

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines. Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

* This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.
* Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.
* Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com

Article Source:http://www.articlesbase.com/diseases-and-conditions-articles/rest-of-world-h1n1-swine-flu-vaccination-market-1403957.html

David Ballard
About H1N1 Virus

Welcome back, keep updated with: h1n1 feed. Thanks again for visiting! Remember to WASH your hands.

Technorati Tags: Baxter, Csl, Flu Vaccination, Glaxo Smith Kline, Government Bodies, Gsk, Influenza, Initial Phase, Intranasal Vaccine, Intranasal Vaccines, Market Opportunity Analysis, Market Revenues, Medimmune, Month Of March, Mutation, Novartis, Pandemic Influenza, Sanofi Pastuer, Swine Flu, Tamiflu

Related Websites

• Real Internet Network Marketing Many times you will see network marketing people talk about how great the compensation plan is.  They will even tell you how easy it is to make money in mlm.  The real nature of network marketing online is far different than what is being sold.  Getting involved in a direct......
• Jagger, Google Analytics, And The Future Of Search & SEO Two big things have just happened in Google-land: Jagger and Google Analytics. Together, these two events may have changed the face of search forever. Jagger First, let's discuss Jagger... Just like hurricanes, Google updates have names. (A Google update is a change to the way Google determines its rankings. Google......
• Prosper Days Day 2 Update The 2nd session was the Big Lender Panel.  It was great.  Worth the price of admission.  The Lenders (with links to their portfolio) were pensioner, L5, and janeybooboo.  They are all manual bidders and from the sound of it they spend quite a bit of time vetting the borrowers.  The biggest thing I......

What don’t they understand about the phrase, “you don’t leave the fox to guard the hen house”. How do… “Executives from Baxter, Novartis, Glaxo-Smith Kline, and Sanofi Pasteur have seats at the advisory group that on July 13th recommended mandatory H1N1 vaccination of everyone in all 194 countries that belong to the World Health Organization (WHO), according to a report just issued by journalist Jane Burgermeister,” end up with the keys to the hen house? [http://www.naturalnews.com/026723_health_vaccines_immune_system.html ]

Attorney Jim Turner is one of a half dozen attorneys involved in the law suit, which seeks to halt the US swine flu vaccination campaign.   “The FDA did not do the proper testing to show safety and efficacy of this vaccine, which is under the law a new drug.

“When I say test data, I don’t mean some professor at some medical school somewhere infected some students and said ‘I don’t see any problems.’

“What I mean is carefully conducted double blind placebo controlled studies trials done in accordance with FDA regulations, and a whole series of them to look at dosing… which are then reviewed by FDA scientists.

“None of that has been done on this vaccination and we’re saying the law requires it to be done,” said Turner. [ http://www.google.com/hostednews/afp/article/ALeqM5i6VRzJ9Ui1F1hDL5fkHn1qo1oDMg ]

“Officials have said the virus is so much like the ordinary flu virus that they don’t need to do special new drug testing on it because it’s just the same old virus with a minor change to it,” said Turner.

So what happens if the World Health Organization (WHO) is successful in passing laws making it mandatory to submit to the H1N1 vaccine. As an individual who may say no, I choose not to be vaccinated, nor for my children to be vaccinated – then what happens? Will we be incarcerated and taken to camps with other who refuse? You would be surprised what is being discussed regarding your rights.

Here are a few thoughts to think about:

MANUFACTURERS HAVE BEEN GRANTED FULL IMMUNITY AGAINST INJURY CLAIMS – WHY IF THEY ARE SO “SAFE”?
WHY AREN’T WE BEING SHOWN THE INGREDIENTS? WHY ARE THE VACCINES APPROVED WITHOUT TESTING?

Technorati Tags: Advisory Group, Double Blind Placebo, Drug Testing, Fda Regulations, Fda Scientists, Flu Vaccination, Flu Virus, Glaxo Smith Kline, Google, Http Www Google Com, Jim Turner, July 13th, Law Suit, Mandatory Vaccination, Novartis, Sanofi, Swine Flu, Test Data, Vaccination Campaign, World Health Organization

Related Websites

• Swine Flu Updates I will be dedicating this post to swine flu updates. --------------------------------------------------------------------------- 07/12/2009 Swine flu is expected to make a comeback with rage this winter. That is why swine flu vaccines are being readied before that season of reckoning. Obese and highly stressed people have a higher probability of mortality based from......
• Great News About Eating Cloned Animals So, lately you have found yourself sitting around wondering when it would finally be possible to eat cloned animals, right? I mean, we all wonder that. In fact, I was thinking about it this morning when I was making bacon and eggs! Well, finally the government has an answer......
• Nine dead in U.S. of swine flu A Utah man who died today is the ninth U.S. victim The worldwide death toll from swine flu had already reached 80 when a man who local officials said died of swine flu succumbed in Salt Lake City Wednesday. Although the Centers for Disease Control has not yet confirmed that......